Market Cap | ₹26,162Cr |
ROE | 19.21% |
P/E Ratio(TTM) | 38.19 |
EPS(TTM) | 43.75 |
P/B Ratio | 7.62 |
Dividend Yield | 0.92% |
Industry P/E | 33.86 |
Book Value | 219.25 |
Debt to Equity | 0.01 |
Face Value | 1 |
Parent Organisation | JB Chemicals & Pharmaceuticals Limited |
Managing Director | NA |
NSE Symbol | JBCHEPHARM |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 100.21 | ||
Emcure Pharmaceuticals | NA (0.00%) | 32.70 | ||
Wockhardt | NA (0.00%) | -176.41 | ||
Concord Biotech | NA (0.00%) | 45.94 |